Sequenta's Series B Round

Sequenta raised a round of funding on December 13, 2010.

Sequenta, formerly MLC Dx, is a biotechnology company dedicated to improving patient care in diseases mediated by immune cells through the discovery and development of novel clinical diagnostics. Sequ…

Articles about Sequenta's Series B Round: